Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Weishen Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2429-2947; OpenAlex author ID A5009021346. Sources: OpenAlex.

Their work

Papers
20 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
67
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 3 papers · 2022: 1 paper · 2023: 8 papers · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 20

  1. A clinician-centric intelligent method towards reliable pancreatic cancer vascular invasion assessment: a retrospective, multi-centre study. Co-author DOI 10.1016/j.lanwpc.2026.101890↗
  2. LLPS-based classification and a novel prognostic signature reveal NRF1 as a therapeutic target in pancreatic cancer. Co-author DOI 10.1186/s12935-026-04395-z↗
  3. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. Co-author DOI 10.1002/advs.202306298↗
  4. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. Co-author DOI 10.1007/s13402-023-00907-5↗
  5. Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement-A retrospective study. Co-author DOI 10.1002/cam4.6687↗
  6. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. Co-author DOI 10.1007/s13402-023-00818-5↗
  7. A dual-transformation with contrastive learning framework for lymph node metastasis prediction in pancreatic cancer. First author DOI 10.1016/j.media.2023.102753↗
  8. A deep-learning radiomics-based lymph node metastasis predictive model for pancreatic cancer: a diagnostic study. Co-author DOI 10.1097/js9.0000000000000469↗
  9. The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12700-z↗
  10. The value of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance whole-body scans and local enhancement scans in the preoperative staging an… Co-author DOI 10.21037/qims-22-731↗
  11. Hypoxia-induced long non-coding RNA LINC00460 promotes p53 mediated proliferation and metastasis of pancreatic cancer by regulating the miR-4689/UBE2V1 axis an… Co-author DOI 10.7150/ijms.87833↗
  12. Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multice… Co-author DOI 10.7150/thno.84978↗
  13. Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal ad… Co-author DOI 10.1016/j.ejso.2021.11.135↗
  14. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes. First author DOI 10.1016/j.pan.2021.02.010↗
  15. Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Cohort Study Co-author DOI 10.21203/rs.3.rs-697919/v1↗
  16. Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.682261↗
  17. Construction and integrated analysis of a lncRNA-associated competing endogenous RNA network reveal functional lncRNAs in pancreatic cancer. Co-author DOI 10.21037/tcr.2020.04.03↗
  18. The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancr… Co-author DOI 10.3389/fonc.2020.01343↗
  19. Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Population Study Using the US SEE… Co-author DOI 10.3389/fonc.2019.01386↗
  20. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic … Co-author DOI 10.1186/s12943-017-0738-0↗

Closest collaborators

The 25 strongest of 67 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baiyong Shen · 13 shared papers, 2017–2024 · strength 1.87
  2. Xiaxing Deng · 10 shared papers, 2019–2024 · strength 1.46
  3. Haoda Chen · 5 shared papers, 2021–2026 · strength 0.93
  4. Chenghong Peng · 7 shared papers, 2017–2024 · strength 0.88
  5. Shuyu Zhai · 5 shared papers, 2020–2024 · strength 0.77
  6. Xiaohua Qian · 3 shared papers, 2023–2026 · strength 0.72
  7. Xiaomei Tang · 4 shared papers, 2021–2024 · strength 0.62
  8. Xiaxing Deng · 4 shared papers, 2017–2024 · strength 0.50
  9. Yizhi Cao · 3 shared papers, 2023–2024 · strength 0.49
  10. Yuanchi Weng · 3 shared papers, 2020–2023 · strength 0.45
  11. Ziyun Shen · 3 shared papers, 2019–2023 · strength 0.42
  12. Ningzhen Fu · 3 shared papers, 2019–2023 · strength 0.42
  13. Baiyong Shen · 2 shared papers, 2023 · strength 0.39
  14. Xinjing Wang · 3 shared papers, 2017–2023 · strength 0.39
  15. Yuchen Ji · 2 shared papers, 2023 · strength 0.38
  16. Chenlei Wen · 3 shared papers, 2017–2024 · strength 0.36
  17. Dongfeng Cheng · 3 shared papers, 2017–2024 · strength 0.35
  18. Hao Chen · 3 shared papers, 2017–2024 · strength 0.35
  19. Yihao Liu · 2 shared papers, 2024 · strength 0.34
  20. Youwei Zhu · 2 shared papers, 2024 · strength 0.34
  21. Yang Liu · 2 shared papers, 2024 · strength 0.34
  22. Pengyi Liu · 2 shared papers, 2024 · strength 0.34
  23. Ronghao Zhang · 2 shared papers, 2023–2024 · strength 0.32
  24. Lihan Qian · 2 shared papers, 2020–2023 · strength 0.31
  25. Hao Chen · 3 shared papers, 2019–2021 · strength 0.31

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.